| $385M | ||
| $350M | ||
| $215M | ||
| $82M | ||
| $76M | ||
| $62M |
Buys | $0 | 0 | – |
Sells | $0 | 0 | – |
Azitra, Inc., a pre-clinical biopharmaceutical company, focuses on developing therapies for precision dermatology using engineered proteins and live biotherapeutic products to treat skin diseases. It is developing ATR-12, a genetically modified strain of S. epidermidis for treating Netherton syndrome, a skin disease; ATR-04, a genetically modified strain of S. epidermidis for treating the papulopustular rash experienced by cancer patients undergoing epidermal growth factor receptor inhibitor; and ATR-01, an engineered recombinant human filaggrin protein for treating ichthyosis vulgaris, a skin disease. The company was incorporated in 2014 and is based in Branford, Connecticut.
Over the last 12 months, insiders at Azitra, Inc. have bought $0 and sold $0 worth of Azitra, Inc. stock.
On average, over the past 5 years, insiders at Azitra, Inc. have bought $7.3M and sold $0 worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 47,600 shares for transaction amount of $10,034 was made by Staskey Norm (Chief Financial Officer) on 2024‑03‑29.
| 2024-03-29 | Staskey Norm | Chief Financial Officer | 47,600 0.2506% | $0.21 | $10,034 | -87.28% | ||
| 2024-02-13 | Salva Francisco D. | President and CEO | 333,300 2.4975% | $0.30 | $99,990 | -97.42% | ||
| 2024-02-13 | Whitfill Travis | Chief Operating Officer | 15,000 0.1124% | $0.30 | $4,500 | -97.42% | ||
| 2024-02-13 | Staskey Norm | Chief Financial Officer | 3,300 0.0247% | $0.30 | $990 | -97.42% | ||
| 2023-06-21 | Kreis Leslie W. | 10 percent owner | 2.3M – | $3.15 | $7.24M | -73.81% | ||
| 2023-06-21 | Fletcher Aaron G.L. | 10 percent owner | 2.3M – | $3.15 | $7.24M | -73.81% |
| Increased Positions | 8 | +200% | 202,672 | +479.31% |
| Decreased Positions | 2 | -50% | 19,523 | -46.17% |
| New Positions | 5 | New | 146,652 | New |
| Sold Out Positions | <1 | Sold Out | 19,519 | Sold Out |
| Total Postitions | 10 | +150% | 225,433 | +433.14% |
| Geode Capital Management, Llc | $6.00 | 0.2% | 21,760 | -2 | <0.01% | 2025-09-30 |
| National Bank Of Canada /Fi/ | $5.00 | 0.18% | 19,519 | <1 | <0.01% | 2025-09-30 |
| Ubs Group Ag | $0 | 0.01% | 862 | -15,629 | -94.77% | 2025-09-30 |
| Tower Research Capital Llc (Trc) | $0 | <0.01% | 103 | -12 | -10.44% | 2025-09-30 |
| Bank Of America Corp /De/ | $0 | 0% | 40 | +17 | +73.91% | 2025-09-30 |
| Hrt Financial Lp | $0 | 0% | 0 | -2,488 | Sold Out | 2025-09-30 |